Literature DB >> 28611788

Prognostic Implications of Chronic Kidney Disease on Patients Presenting with ST-Segment Elevation Myocardial Infarction with versus without Stent Thrombosis.

Gilad Margolis1, Shahar Vig1, Nir Flint1, Shafik Khoury1, Michael Barkagan1, Gad Keren1, Yacov Shacham1.   

Abstract

BACKGROUND: Limited data is present regarding long-term outcomes in chronic kidney disease (CKD) patients presenting with stent thrombosis (ST). We evaluated the possible implications of CKD on long-term mortality in patients presenting with ST-segment elevation myocardial infarction (STEMI) and treated with primary percutaneous coronary intervention (PCI), and its interaction with the presence of ST.
METHODS: We retrospectively studied 1,722 STEMI patients treated with primary PCI. Baseline CKD was categorized as an estimated glomerular filtration rate <60 mL/min/1.73 m2 at presentation. The presence of ST was determined using the Academic Research Consortium definitions. Patients were evaluated for the presence of CKD and ST, as well as for long-term mortality.
RESULTS: A total of 448/1,722 (26%) patients had baseline CKD. Patients with CKD were older and had more comorbidities and a higher rate of ST (4 vs. 7%, respectively, p < 0.001). In a univariate analysis, long-term mortality was significantly higher among those with CKD compared to those without CKD (17.6 vs. 2.7%, p < 0.001). The presence of ST did not alter long-term mortality in both CKD and no-CKD patients. In a Cox regression model, CKD was an independent predictor of long-term mortality (hazard ratio 2.04, 95% confidence interval 1.17-3.56, p = 0.01), while ST as a covariate was not significantly associated with long-term mortality.
CONCLUSION: Among STEMI patients, CKD, but not ST, is a predictor of long-term mortality.

Entities:  

Keywords:  Acute myocardial infarction; Chronic kidney disease; Mortality; Percutaneous coronary intervention; Stent thrombosis

Year:  2017        PMID: 28611788      PMCID: PMC5465745          DOI: 10.1159/000455905

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  25 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.

Authors:  Duk-Woo Park; Seong-Wook Park; Kyoung-Ha Park; Bong-Ki Lee; Young-Hak Kim; Cheol Whan Lee; Myeong-Ki Hong; Jae-Joong Kim; Seung-Jung Park
Journal:  Am J Cardiol       Date:  2006-06-12       Impact factor: 2.778

3.  Moderate-severe renal insufficiency is a risk factor for sirolimus-eluting stent thrombosis. The RIFT study.

Authors:  Zheng Bin Zhu; Rui Yan Zhang; Qi Zhang; Jian Sheng Zhang; Jian Hu; Zhen Kun Yang; Wei Feng Shen
Journal:  Cardiology       Date:  2008-08-01       Impact factor: 1.869

4.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Jacqueline E Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  Circulation       Date:  2012-12-17       Impact factor: 29.690

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

6.  Acute Cardio-Renal Syndrome as a Cause for Renal Deterioration Among Myocardial Infarction Patients Treated With Primary Percutaneous Intervention.

Authors:  Yacov Shacham; Eran Leshem-Rubinow; Amir Gal-Oz; Yaron Arbel; Gad Keren; Arie Roth; Arie Steinvil
Journal:  Can J Cardiol       Date:  2015-04-02       Impact factor: 5.223

7.  Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition.

Authors:  F Gaspari; G Viganò; S Orisio; M Bonati; M Livio; G Remuzzi
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

8.  Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.

Authors:  Michael G Shlipak; Paul A Heidenreich; Haruko Noguchi; Glenn M Chertow; Warren S Browner; Mark B McClellan
Journal:  Ann Intern Med       Date:  2002-10-01       Impact factor: 25.391

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

10.  Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.

Authors:  John M Lasala; David A Cox; David Dobies; Kenneth Baran; William B Bachinsky; Edwin W Rogers; Jeffrey A Breall; David H Lewis; Aijun Song; Ruth M Starzyk; Stephen R Mascioli; Keith D Dawkins; Donald S Baim
Journal:  Circ Cardiovasc Interv       Date:  2009-07-22       Impact factor: 6.546

View more
  4 in total

1.  Renoprotective effect of remote ischemic postconditioning in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Bangming Cao; Chi Zhang; Haipeng Wang; Ming Xia; Xiangjun Yang
Journal:  Ther Clin Risk Manag       Date:  2018-02-22       Impact factor: 2.423

2.  Impact of Renal Insufficiency on Prognosis of Patients with Acute Coronary Syndrome.

Authors:  Lingyao Qi; Hanxiong Liu; Lianchao Cheng; Caiyan Cui; Xu Chen; Siqi Yang; Lin Cai
Journal:  Int J Gen Med       Date:  2021-11-26

3.  Adverse outcomes associated with rapid linear and non-linear patterns of chronic kidney disease progression.

Authors:  Ibrahim Ali; Rajkumar Chinnadurai; Sara T Ibrahim; Philip A Kalra
Journal:  BMC Nephrol       Date:  2021-03-06       Impact factor: 2.388

4.  The outcome of patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) and impaired kidney function: a 3-year observational study.

Authors:  Malgorzata Zalewska-Adamiec; Jolanta Malyszko; Ewelina Grodzka; Lukasz Kuzma; Slawomir Dobrzycki; Hanna Bachorzewska-Gajewska
Journal:  Int Urol Nephrol       Date:  2021-02-18       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.